BCG July 18, 2024
By Torben Danger

Headquartered in Cambridge, Massachusetts, Biogen is a global biotechnology company that has pioneered innovative therapies for multiple sclerosis, spinal muscular dystrophy, and Alzheimer’s disease. Chief Financial Officer Mike McDonnell sat down with BCG’s Torben Danger to discuss Fit for Growth, the company’s bold transformation initiative, and employees’ role in making it a success. The discussion also touched on leadership, inorganic growth, and AI. Edited excerpts of the conversation follow.

Biogen CFO Mike McDonnell on the leadership lessons he learned from his roles across different industries.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
Sanofi, expanding in radiopharma, strikes a joint venture deal
Sage to cut one-third of workforce, streamline drug pipeline
After rejections, AbbVie secures approval for Parkinson’s drug
Wave surges on first RNA editing data in humans
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Share This Article